# SeaStar Medical Holding Corp: filings

ICU · Nasdaq · CIK 1831868 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/icu.md) · [Financials](/companies/icu/financials.md) · [Filings](/companies/icu/filings.md) · [Insiders](/companies/icu/insiders.md)

## Reports and events: 165 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 105, 4 84, 424B3 79, CORRESP 28, UPLOAD 24, 3 22, EFFECT 22, 10-Q 17, 425 12, POS AM 12, 424B5 11, S-1 10, 8-K/A 8, DEF 14A 8, SC 13G 8, SC 13G/A 8, PRE 14A 7, S-3 7, 10-K 6, S-1/A 6, SCHEDULE 13G/A 6, S-3/A 5, S-8 5, 10-K/A 4, 4/A 4, NT 10-Q 4, S-4/A 4, SCHEDULE 13G 3, 424B4 2, ARS 2, D 2, DEFA14A 2, DRS 2, NT 10-K 2, 15-15D 1, 25-NSE 1, 424B7 1, 8-A12B 1, 8-A12B/A 1, CERT 1, DEFR14A 1, RW 1, S-1MEF 1, S-4 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 16:20 ET | [8-K](/filings/0001437749-26-032035.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032035 |
| 2026-08-12 | 16:46 ET | [10-Q](/filings/0001437749-26-027353.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027353 |
| 2026-08-12 | 16:10 ET | [8-K](/filings/0001437749-26-027314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027314 |
| 2026-07-01 | 16:06 ET | [8-K](/filings/0001437749-26-022278.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-022278 |
| 2026-06-23 | 16:14 ET | [8-K/A](/filings/0001437749-26-021441.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-021441 |
| 2026-06-17 | 16:07 ET | [8-K](/filings/0001437749-26-020967.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-020967 |
| 2026-05-13 | 16:45 ET | [10-Q](/filings/0001437749-26-016764.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016764 |
| 2026-05-13 | 16:12 ET | [8-K](/filings/0001437749-26-016726.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016726 |
| 2026-05-07 | 08:38 ET | [S-1/A](/filings/0001213900-26-053076.md) | Registration statement, amended | 0001213900-26-053076 |
| 2026-04-29 | 16:10 ET | [DEF 14A](/filings/0001437749-26-013871.md) | Proxy statement, period 2026-06-17 | 0001437749-26-013871 |
| 2026-04-28 | 16:45 ET | [S-1](/filings/0001213900-26-048608.md) | Registration statement | 0001213900-26-048608 |
| 2026-04-28 | 16:04 ET | [8-K](/filings/0001437749-26-013653.md) | 8.01 Other events | 0001437749-26-013653 |
| 2026-03-25 | 16:45 ET | [10-K](/filings/0001437749-26-009797.md) | Annual report, period 2025-12-31 | 0001437749-26-009797 |
| 2026-03-25 | 16:10 ET | [8-K](/filings/0001437749-26-009780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-009780 |
| 2026-01-20 | 16:03 ET | [8-K](/filings/0001437749-26-001541.md) | 8.01 Other events | 0001437749-26-001541 |
| 2025-12-23 | 16:44 ET | [8-K/A](/filings/0001437749-25-038701.md) | 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038701 |
| 2025-12-18 | 16:22 ET | [8-K](/filings/0001437749-25-038276.md) | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results | 0001437749-25-038276 |
| 2025-11-17 | 16:56 ET | [8-K](/filings/0001437749-25-035449.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-035449 |
| 2025-11-14 | 16:31 ET | [DEF 14A](/filings/0001213900-25-110923.md) | Proxy statement, period 2025-12-18 | 0001213900-25-110923 |
| 2025-11-13 | 16:53 ET | [10-Q](/filings/0001437749-25-034884.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034884 |
| 2025-11-13 | 16:12 ET | [8-K](/filings/0001437749-25-034834.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034834 |
| 2025-09-29 | 16:28 ET | [8-K](/filings/0001437749-25-030023.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-030023 |
| 2025-09-24 | 17:00 ET | [8-K](/filings/0001193125-25-215608.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-215608 |
| 2025-08-19 | 16:05 ET | [8-K](/filings/0001831868-25-000014.md) | 5.02 Departure or appointment of officers or directors | 0001831868-25-000014 |
| 2025-08-14 | 09:07 ET | [8-K/A](/filings/0001831868-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831868-25-000011 |
| 2025-08-13 | 16:45 ET | [10-Q](/filings/0001831868-25-000007.md) | Quarterly report, period 2025-06-30 | 0001831868-25-000007 |
| 2025-08-13 | 16:15 ET | [8-K](/filings/0001831868-25-000006.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001831868-25-000006 |
| 2025-08-08 | 17:02 ET | [S-1](/filings/0001213900-25-073745.md) | Registration statement | 0001213900-25-073745 |
| 2025-08-08 | 16:30 ET | [8-K](/filings/0000950170-25-105906.md) | 8.01 Other events | 0000950170-25-105906 |
| 2025-08-06 | 19:42 ET | [8-K/A](/filings/0000950170-25-103356.md) | 3.01 Delisting notice | 0000950170-25-103356 |
| 2025-08-06 | 17:57 ET | [8-K](/filings/0000950170-25-103274.md) | 3.01 Delisting notice | 0000950170-25-103274 |
| 2025-08-01 | 16:05 ET | [8-K](/filings/0000950170-25-101408.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-101408 |
| 2025-07-16 | 16:05 ET | [8-K](/filings/0000950170-25-096244.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-096244 |
| 2025-07-14 | 06:24 ET | [8-K](/filings/0001213900-25-063450.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-063450 |
| 2025-07-08 | 06:30 ET | [8-K](/filings/0000950170-25-094442.md) | 5.07 Shareholder vote results | 0000950170-25-094442 |
| 2025-07-02 | 16:59 ET | [8-K](/filings/0000950170-25-093142.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-093142 |
| 2025-06-23 | 07:16 ET | [8-K](/filings/0000950170-25-088707.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events | 0000950170-25-088707 |
| 2025-06-20 | 06:44 ET | [S-1/A](/filings/0001213900-25-055807.md) | Registration statement, amended | 0001213900-25-055807 |
| 2025-06-16 | 08:41 ET | [S-1](/filings/0001213900-25-054502.md) | Registration statement | 0001213900-25-054502 |
| 2025-06-11 | 16:30 ET | [8-K](/filings/0001213900-25-053463.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-053463 |
| 2025-05-19 | 17:01 ET | [S-1](/filings/0001213900-25-045463.md) | Registration statement | 0001213900-25-045463 |
| 2025-05-14 | 17:00 ET | [10-Q](/filings/0000950170-25-071583.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071583 |
| 2025-05-14 | 16:10 ET | [8-K](/filings/0000950170-25-071390.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071390 |
| 2025-05-06 | 09:05 ET | [DEF 14A](/filings/0001213900-25-040244.md) | Proxy statement, period 2025-07-03 | 0001213900-25-040244 |
| 2025-04-25 | 17:13 ET | [8-K](/filings/0000950170-25-058860.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-058860 |
| 2025-04-23 | 16:05 ET | [10-K/A](/filings/0000950170-25-057332.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-057332 |
| 2025-03-28 | 16:23 ET | [8-K](/filings/0000950170-25-046827.md) | 5.07 Shareholder vote results | 0000950170-25-046827 |
| 2025-03-27 | 17:15 ET | [10-K](/filings/0000950170-25-046200.md) | Annual report, period 2024-12-31 | 0000950170-25-046200 |
| 2025-03-27 | 16:10 ET | [8-K](/filings/0000950170-25-046069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046069 |
| 2025-03-21 | 16:05 ET | [8-K](/filings/0000950170-25-043183.md) | 5.07 Shareholder vote results | 0000950170-25-043183 |

Page 1 of 4. [Older](/companies/icu/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:17 ET. No prices; not investment advice.